{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:37:32Z","timestamp":1792859852628,"version":"4.5.0"},"reference-count":191,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.autrev.2026.104148","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:28:17Z","timestamp":1785194897000},"page":"104148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Siglec-9: A pivotal immune checkpoint connecting immune homeostasis with the pathogenesis of multiple diseases"],"prefix":"10.1016","volume":"25","author":[{"given":"Yi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minming","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2026.104148_bb0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.maturitas.2017.04.014","article-title":"The mechanisms tumor cells utilize to evade the host\u2019s immune system","volume":"105","author":"Kuol","year":"2017","journal-title":"Maturitas"},{"key":"10.1016\/j.autrev.2026.104148_bb0010","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.carres.2008.01.009","article-title":"CD33-related sialic-acid-binding immunoglobulin-like lectins in health and disease","volume":"343","author":"McMillan","year":"2008","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.autrev.2026.104148_bb0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2567.2010.03368.x","article-title":"Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?","volume":"132","author":"Cao","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2026.104148_bb0020","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/imr.12526","article-title":"Viewing Siglecs through the lens of tumor immunology","volume":"276","author":"Fraschilla","year":"2017","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2026.104148_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.743515","article-title":"Siglec-9, a putative immune checkpoint marker for cancer progression across multiple cancer types","volume":"9","author":"Wu","year":"2022","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.autrev.2026.104148_bb0030","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/resp.12952","article-title":"Influence of SIGLEC9 polymorphisms on COPD phenotypes including exacerbation frequency","volume":"22","author":"Ishii","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.autrev.2026.104148_bb0035","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/sji.12543","article-title":"Siglec-9 is upregulated in rheumatoid arthritis and suppresses collagen-induced arthritis through reciprocal regulation of Th17\u2212\/Treg-cell differentiation","volume":"85","author":"Wang","year":"2017","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2026.104148_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.139394","article-title":"Identification of potential therapeutic targets for Alzheimer\u2019s disease from the proteomes of plasma and cerebrospinal fluid in a multicenter Mendelian randomization study","volume":"294","author":"Wang","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.autrev.2026.104148_bb0045","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/s41467-021-21550-4","article-title":"Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9","volume":"12","author":"Rodriguez","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2026.104148_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-020-01359-5","article-title":"Cancer-associated hypersialylated MUC1 drives the differentiation of human monocytes into macrophages with a pathogenic phenotype","volume":"3","author":"Beatson","year":"2020","journal-title":"Commun Biol"},{"key":"10.1016\/j.autrev.2026.104148_bb0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/geno.2000.6208","article-title":"Identification and molecular characterization of a novel member of the SIGLEC family (SIGLEC9)","volume":"67","author":"Foussias","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/j.autrev.2026.104148_bb0060","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1139\/gen-2014-0083","article-title":"Gene conversions are frequent but not under positive selection in the Siglec gene families of primates","volume":"57","author":"Zid","year":"2014","journal-title":"Genome"},{"key":"10.1016\/j.autrev.2026.104148_bb0065","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1006\/bbrc.2000.3866","article-title":"Molecular characterization of a Siglec8 variant containing cytoplasmic tyrosine-based motifs, and mapping of the Siglec8 gene","volume":"278","author":"Foussias","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2026.104148_bb0070","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1006\/bbrc.2001.5053","article-title":"Molecular characterization, tissue expression, and mapping of a novel Siglec-like gene (SLG2) with three splice variants","volume":"284","author":"Yousef","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2026.104148_bb0075","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1096\/fj.13-241497","article-title":"Rapid evolution of binding specificities and expression patterns of inhibitory CD33-related Siglecs in primates","volume":"28","author":"Padler-Karavani","year":"2014","journal-title":"FASEB J"},{"key":"10.1016\/j.autrev.2026.104148_bb0080","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1021\/acschembio.3c00664","article-title":"Unraveling molecular recognition of glycan ligands by Siglec-9 via NMR spectroscopy and molecular dynamics modeling","volume":"19","author":"Atxabal","year":"2024","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.autrev.2026.104148_bb0085","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1074\/jbc.M210602200","article-title":"High resolution crystal structures of Siglec-7. Insights into ligand specificity in the Siglec family","volume":"278","author":"Alphey","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2026.104148_bb0090","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1074\/jbc.M110146200","article-title":"A small region of the natural killer cell receptor, Siglec-7, is responsible for its preferred binding to alpha 2,8-disialyl and branched alpha 2,6-sialyl residues. A comparison with Siglec-9","volume":"277","author":"Yamaji","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2026.104148_bb0095","doi-asserted-by":"crossref","first-page":"43117","DOI":"10.1074\/jbc.M403538200","article-title":"Negative regulation of T cell receptor signaling by Siglec-7 (p70\/AIRM) and Siglec-9","volume":"279","author":"Ikehara","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2026.104148_bb0100","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.4049\/jimmunol.173.11.6841","article-title":"The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells","volume":"173","author":"Avril","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2026.104148_bb0105","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1074\/jbc.M116.738351","article-title":"Studies on the detection, expression, glycosylation, dimerization, and ligand binding properties of mouse Siglec-E","volume":"292","author":"Siddiqui","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2026.104148_bb0110","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1042\/bj3530483","article-title":"mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2","volume":"353","author":"Yu","year":"2001","journal-title":"Biochem J"},{"key":"10.1016\/j.autrev.2026.104148_bb0115","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2249.2012.04599.x","article-title":"Inhibitory receptor expression on neonatal immune cells","volume":"169","author":"Walk","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2026.104148_bb0120","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1203\/PDR.0b013e3181b1bc19","article-title":"Siglec-9 and SHP-1 are differentially expressed in neonatal and adult neutrophils","volume":"66","author":"Rashmi","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.autrev.2026.104148_bb0125","doi-asserted-by":"crossref","first-page":"22121","DOI":"10.1074\/jbc.M002788200","article-title":"Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes","volume":"275","author":"Zhang","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2026.104148_bb0130","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1172\/JCI65899","article-title":"Interactions between Siglec-7\/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance","volume":"124","author":"Jandus","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2026.104148_bb0135","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1158\/2326-6066.CIR-18-0505","article-title":"Siglec-9 regulates an effector memory CD8+ T-cell subset that congregates in the melanoma tumor microenvironment","volume":"7","author":"Haas","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.autrev.2026.104148_bb0140","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s12026-017-8942-y","article-title":"Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans","volume":"65","author":"Rosenstock","year":"2017","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2026.104148_bb0145","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jaci.2023.04.007","article-title":"Siglec-9 is an inhibitory receptor on human mast cells in vitro","volume":"152","author":"Miralda","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2026.104148_bb0150","doi-asserted-by":"crossref","first-page":"10116","DOI":"10.1038\/s41598-017-09120-5","article-title":"Increased expression of Siglec-9 in chronic obstructive pulmonary disease","volume":"7","author":"Zeng","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2026.104148_bb0155","first-page":"123","article-title":"Preliminary study on the role of siglec-9 expression in peripheral blood of acute respiratory distress syndrome patients","volume":"48","author":"Liu","year":"2025","journal-title":"J Tuberc Respir Dis"},{"key":"10.1016\/j.autrev.2026.104148_bb0160","article-title":"Soluble immune checkpoints are dysregulated in patients with sickle cell disease and correlate with inflammatory mediators, autoantibodies, immune cell profiles, and clinical outcomes","author":"Li","year":"2025","journal-title":"MedRxiv Prepr Serv Health Sci"},{"key":"10.1016\/j.autrev.2026.104148_bb0165","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10753-023-01932-0","article-title":"Supplementing glucose intake reverses the inflammation induced by a high-fat diet by increasing the expression of Siglec-E ligands on erythrocytes","volume":"47","author":"Liu","year":"2024","journal-title":"Inflammation"},{"key":"10.1016\/j.autrev.2026.104148_bb0170","article-title":"Comprehensive modular synthesis of ganglioside glycans and evaluation of their binding affinities to Siglec-7 and Siglec-9","volume":"12","author":"Adak","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.autrev.2026.104148_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.identj.2025.100958","article-title":"Initial insights into the NET-associated ceRNA network in pulpitis: transcriptomic and functional exploration","volume":"75","author":"Guo","year":"2025","journal-title":"Int Dent J"},{"key":"10.1016\/j.autrev.2026.104148_bb0180","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/glycob\/cwp195","article-title":"Siglec-7 mediates nonapoptotic cell death independently of its immunoreceptor tyrosine-based inhibitory motifs in monocytic cell line U937","volume":"20","author":"Mitsuki","year":"2010","journal-title":"Glycobiology"},{"key":"10.1016\/j.autrev.2026.104148_bb0185","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bbrc.2014.06.009","article-title":"A soluble form of Siglec-9 provides an antitumor benefit against mammary tumor cells expressing MUC1 in transgenic mice","volume":"450","author":"Tomioka","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2026.104148_bb0190","doi-asserted-by":"crossref","first-page":"33481","DOI":"10.1074\/jbc.M114.593129","article-title":"Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs","volume":"289","author":"L\u00e4ubli","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2026.104148_bb0195","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1016\/j.csbj.2023.08.014","article-title":"Sequence variety in the CC\u2019 loop of Siglec-8\/9\/3 determines the recognitions to sulfated oligosaccharides","volume":"21","author":"Wang","year":"2023","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.autrev.2026.104148_bb0200","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1134\/S0006297906050051","article-title":"Probing sialic acid binding Ig-like lectins (siglecs) with sulfated oligosaccharides","volume":"71","author":"Rapoport","year":"2006","journal-title":"Biochem Biokhimiia"},{"key":"10.1016\/j.autrev.2026.104148_bb0205","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1021\/acschembio.6b00928","article-title":"A chemical biology solution to problems with studying biologically important but unstable 9-O-acetyl sialic acids","volume":"12","author":"Khedri","year":"2017","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.autrev.2026.104148_bb0210","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s13075-017-1460-4","article-title":"Targeting of vascular adhesion protein-1 by positron emission tomography visualizes sites of inflammation in Borrelia burgdorferi-infected mice","volume":"19","author":"Siitonen","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2026.104148_bb0215","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/glycob\/cwh039","article-title":"A uniquely human consequence of domain-specific functional adaptation in a sialic acid-binding receptor","volume":"14","author":"Sonnenburg","year":"2004","journal-title":"Glycobiology"},{"key":"10.1016\/j.autrev.2026.104148_bb0220","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0960-894X(02)00998-8","article-title":"Ganglioside binding pattern of CD33-related siglecs","volume":"13","author":"Rapoport","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.autrev.2026.104148_bb0225","first-page":"452","article-title":"MUC16: the novel target for tumor therapy","volume":"25","author":"Gao","year":"2022","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"10.1016\/j.autrev.2026.104148_bb0230","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1073\/pnas.1813020116","article-title":"The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins","volume":"116","author":"Malaker","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2026.104148_bb0235","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/ni.3552","article-title":"The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9","volume":"17","author":"Beatson","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2026.104148_bb0240","doi-asserted-by":"crossref","first-page":"31842","DOI":"10.1074\/jbc.M113.471318","article-title":"Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of \u03b2-catenin and subsequent cell growth","volume":"288","author":"Tanida","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2026.104148_bb0245","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180282","article-title":"Sialylated glycoproteins suppress immune cell killing by binding to Siglec-7 and Siglec-9 in prostate cancer","volume":"134","author":"Wen","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2026.104148_bb0250","article-title":"Proximity labeling and genetic screening reveal that DSG2 is a counter receptor of Siglec-9 and suppresses macrophage phagocytosis","volume":"12","author":"Wu","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.autrev.2026.104148_bb0255","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/j.jtha.2025.03.027","article-title":"Sialylated glycoproteins bind to Siglec-9 in a cis manner on platelets to suppress platelet activation","volume":"23","author":"She","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2026.104148_bb0260","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00109-015-1341-8","article-title":"Host and pathogen hyaluronan signal through human siglec-9 to suppress neutrophil activation","volume":"94","author":"Secundino","year":"2016","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.autrev.2026.104148_bb0265","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bone.2015.11.012","article-title":"Factors secreted from dental pulp stem cells show multifaceted benefits for treating experimental rheumatoid arthritis","volume":"83","author":"Ishikawa","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.autrev.2026.104148_bb0270","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/icb.2017.63","article-title":"Tamm-Horsfall glycoprotein engages human Siglec-9 to modulate neutrophil activation in the urinary tract","volume":"95","author":"Patras","year":"2017","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.autrev.2026.104148_bb0275","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.4049\/jimmunol.1100605","article-title":"Colonic epithelial cells express specific ligands for mucosal macrophage immunosuppressive receptors siglec-7 and -9","volume":"188","author":"Miyazaki","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2026.104148_bb0280","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000320225","article-title":"A novel function of Siglec-9 A391C polymorphism on T cell receptor signaling","volume":"154","author":"Cheong","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.autrev.2026.104148_bb0285","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.bbrc.2013.03.085","article-title":"Prohibitins function as endogenous ligands for Siglec-9 and negatively regulate TCR signaling upon ligation","volume":"434","author":"Yurugi","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2026.104148_bb0290","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3389\/fimmu.2019.01047","article-title":"Sugar free: novel immunotherapeutic approaches targeting Siglecs and sialic acids to enhance natural killer cell cytotoxicity against cancer","volume":"10","author":"Daly","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104148_bb0295","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1021\/acscentsci.3c00969","article-title":"Dissecting the ability of Siglecs to antagonize Fc\u03b3 receptors","volume":"10","author":"McCord","year":"2024","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.autrev.2026.104148_bb0300","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbrc.2008.02.111","article-title":"Siglec-9 enhances IL-10 production in macrophages via tyrosine-based motifs","volume":"369","author":"Ando","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2026.104148_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00649","article-title":"The fab fragment of a human anti-Siglec-9 monoclonal antibody suppresses LPS-induced inflammatory responses in human macrophages","volume":"7","author":"Chu","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104148_bb0310","article-title":"Siglec receptors modulate dendritic cell activation and antigen presentation to T cells in cancer","volume":"10","author":"Wang","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.autrev.2026.104148_bb0315","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/icb.2016.105","article-title":"Metabolic sialic acid blockade lowers the activation threshold of moDCs for TLR stimulation","volume":"95","author":"B\u00fcll","year":"2017","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.autrev.2026.104148_bb0320","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/09168451.2015.1104238","article-title":"Siglec-9 modulated IL-4 responses in the macrophage cell line RAW264","volume":"80","author":"Higuchi","year":"2016","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.autrev.2026.104148_bb0325","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1080\/09168451.2016.1146070","article-title":"Constitutively expressed Siglec-9 inhibits LPS-induced CCR7, but enhances IL-4-induced CD200R expression in human macrophages","volume":"80","author":"Higuchi","year":"2016","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.autrev.2026.104148_bb0330","doi-asserted-by":"crossref","DOI":"10.1093\/immadv\/ltab012","article-title":"\u03b12-3 sialic acid binding and uptake by human monocyte-derived dendritic cells alters metabolism and cytokine release and initiates tolerizing T cell programming","volume":"1","author":"L\u00fcbbers","year":"2021","journal-title":"Immunother Adv"},{"key":"10.1016\/j.autrev.2026.104148_bb0335","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13075-016-1035-9","article-title":"Soluble Siglec-9 suppresses arthritis in a collagen-induced arthritis mouse model and inhibits M1 activation of RAW264.7 macrophages","volume":"18","author":"Matsumoto","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2026.104148_bb0340","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1021\/bi301461t","article-title":"Immunoreceptor tyrosine-based inhibitory motif (ITIM)-mediated inhibitory signaling is regulated by sequential phosphorylation mediated by distinct nonreceptor tyrosine kinases: a case study involving PECAM-1","volume":"52","author":"Tourdot","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.autrev.2026.104148_bb0345","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10616-014-9691-6","article-title":"Lectin-dependent localization of cell surface sialic acid-binding lectin Siglec-9","volume":"67","author":"Ando","year":"2015","journal-title":"Cytotechnology"},{"key":"10.1016\/j.autrev.2026.104148_bb0350","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4161\/auto.3436","article-title":"Autophagic-like cell death in neutrophils induced by autoantibodies","volume":"3","author":"von Gunten","year":"2007","journal-title":"Autophagy"},{"key":"10.1016\/j.autrev.2026.104148_bb0355","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/SHK.0b013e3181a1bc98","article-title":"Different patterns of Siglec-9-mediated neutrophil death responses in septic shock","volume":"32","author":"von Gunten","year":"2009","journal-title":"Shock Augusta Ga"},{"key":"10.1016\/j.autrev.2026.104148_bb0360","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1182\/blood-2004-10-4112","article-title":"Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment","volume":"106","author":"von Gunten","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2026.104148_bb0365","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/glycob\/cwi048","article-title":"Characterization of inhibitory signaling motifs of the natural killer cell receptor Siglec-7: attenuated recruitment of phosphatases by the receptor is attributed to two amino acids in the motifs","volume":"15","author":"Yamaji","year":"2005","journal-title":"Glycobiology"},{"key":"10.1016\/j.autrev.2026.104148_bb0380","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/s43018-023-00598-9","article-title":"Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response","volume":"4","author":"Mei","year":"2023","journal-title":"Nat Cancer"},{"key":"10.1016\/j.autrev.2026.104148_bb0385","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adf5302","article-title":"Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma","volume":"15","author":"Schmassmann","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2026.104148_bb0410","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007099","article-title":"Siglec-9+ tumor-associated macrophages delineate an immunosuppressive subset with therapeutic vulnerability in patients with high-grade serous ovarian cancer","volume":"11","author":"Wang","year":"2023","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.autrev.2026.104148_bb0440","article-title":"The role of SIGLEC9 in immunosuppression and prognosis in cervical cancer","volume":"81","author":"Wang","year":"2025","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.autrev.2026.104148_bb0445","doi-asserted-by":"crossref","first-page":"13617","DOI":"10.3390\/cimb46120814","article-title":"Association of SIGLEC9 expression with cytokine expression, tumor grading, KRAS, NRAS, BRAF, PIK3CA, AKT gene mutations, and MSI status in colorectal cancer","volume":"46","author":"Ochman","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.autrev.2026.104148_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112475","article-title":"Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment","volume":"42","author":"Egan","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.autrev.2026.104148_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111771","article-title":"Siglec9 + tumor-associated macrophages predict prognosis and therapeutic vulnerability in patients with colon cancer","volume":"130","author":"Chang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2026.104148_bb0460","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jhep.2024.01.028","article-title":"Increased Siglec-9\/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapy","volume":"80","author":"Xiao","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2026.104148_bb0470","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2517415122","article-title":"Improving the efficacy of anti-SSEA4 antibody in pancreatic cancer immunotherapy with glyco-optimization and immune checkpoint blockade","volume":"122","author":"Chuang","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2026.104148_bb0475","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s00262-022-03364-5","article-title":"LINC01004-SPI1 axis-activated SIGLEC9 in tumor-associated macrophages induces radioresistance and the formation of immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma","volume":"72","author":"Zhao","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.autrev.2026.104148_bb0480","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2503081122","article-title":"Tumor-expressed GPNMB orchestrates Siglec-9+ TAM polarization and EMT to promote metastasis in triple-negative breast cancer","volume":"122","author":"Dang Cao","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2026.104148_bb0490","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1488668","article-title":"Sialylation inhibition improves macrophage mediated tumor cell phagocytosis of breast cancer cells triggered by therapeutic antibodies of different isotypes","volume":"14","author":"Lustig","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.autrev.2026.104148_bb0375","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s42003-024-05924-0","article-title":"ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer","volume":"7","author":"Garnham","year":"2024","journal-title":"Commun Biol"},{"key":"10.1016\/j.autrev.2026.104148_bb0370","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41375-024-02454-w","article-title":"The glycosyltransferase ST3GAL4 drives immune evasion in acute myeloid leukemia by synthesizing ligands for the glyco-immune checkpoint receptor Siglec-9","volume":"39","author":"Krishnamoorthy","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.autrev.2026.104148_bb0510","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.leukres.2006.05.026","article-title":"Analysis of the CD33-related siglec family reveals that Siglec-9 is an endocytic receptor expressed on subsets of acute myeloid leukemia cells and absent from normal hematopoietic progenitors","volume":"31","author":"Biedermann","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.autrev.2026.104148_bb0520","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.3390\/ijms26052233","article-title":"Insights on the role of sialic acids in acute lymphoblastic leukemia in children","volume":"26","author":"Radu","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2026.104148_bb0525","doi-asserted-by":"crossref","DOI":"10.1186\/s13000-024-01536-8","article-title":"Prognostic and immune infiltration implications of SIGLEC9 in SKCM","volume":"19","author":"Yang","year":"2024","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.autrev.2026.104148_bb0535","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12957-021-02367-3","article-title":"Comprehensive analysis of angiogenesis subtype of squamous cell carcinoma","volume":"19","author":"Qin","year":"2021","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.autrev.2026.104148_bb0540","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1172\/JCI120612","article-title":"Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells","volume":"128","author":"Stanczak","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2026.104148_bb0545","article-title":"HIV-induced sialoglycans on infected cells promote immune evasion from myeloid cell-mediated killing","author":"Singh","year":"2025","journal-title":"BioRxiv Prepr Serv Biol"},{"key":"10.1016\/j.autrev.2026.104148_bb0550","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66540-y","article-title":"HIV-induced sialoglycans on infected CD4+ T cells promote immune evasion from myeloid cell-mediated killing","volume":"17","author":"Singh","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2026.104148_bb0555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010034","article-title":"Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells","volume":"17","author":"Adeniji","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.autrev.2026.104148_bb0560","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41590-024-01776-2","article-title":"The receptor binding domain of SARS-CoV-2 omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis","volume":"25","author":"He","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2026.104148_bb0575","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01124","article-title":"Decreased Siglec-9 expression on natural killer cell subset associated with persistent HBV replication","volume":"9","author":"Zhao","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104148_bb0580","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.imlet.2023.10.004","article-title":"The change of Siglec-9 expression in peripheral blood NK cells of SFTS patients can affect the function of NK cells","volume":"263","author":"Zhang","year":"2023","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2026.104148_bb0585","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.1073\/pnas.1815572116","article-title":"Dual actions of group B Streptococcus capsular sialic acid provide resistance to platelet-mediated antimicrobial killing","volume":"116","author":"Uchiyama","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2026.104148_bb0590","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1182\/blood-2008-11-187302","article-title":"Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response","volume":"113","author":"Carlin","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2026.104148_bb0600","doi-asserted-by":"crossref","first-page":"673","DOI":"10.4161\/viru.32076","article-title":"Sialic acid involved in hypermucoviscosity phenotype of Klebsiella pneumoniae and associated with resistance to neutrophil phagocytosis","volume":"5","author":"Lee","year":"2014","journal-title":"Virulence"},{"key":"10.1016\/j.autrev.2026.104148_bb0605","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1189\/jlb.0511260","article-title":"Sialoglycoproteins adsorbed by Pseudomonas aeruginosa facilitate their survival by impeding neutrophil extracellular trap through siglec-9","volume":"91","author":"Khatua","year":"2012","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2026.104148_bb0615","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00430-015-0421-2","article-title":"Involvement of sulfates from cruzipain, a major antigen of Trypanosoma cruzi, in the interaction with immunomodulatory molecule Siglec-E","volume":"205","author":"Ferrero","year":"2016","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.autrev.2026.104148_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156558","article-title":"Expression of Siglec-9 in peripheral blood neutrophils was increased and associated with disease severity in patients with AECOPD","volume":"177","author":"Ge","year":"2024","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2026.104148_bb0635","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000484873","article-title":"Targeting neutrophils in severe asthma via Siglec-9","volume":"175","author":"Chen","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.autrev.2026.104148_bb0640","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/ACI.0000000000000234","article-title":"Regulation of airway inflammation by Siglec-8 and Siglec-9 sialoglycan ligand expression","volume":"16","author":"Schleimer","year":"2016","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2026.104148_bb0645","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/glycob\/cwx026","article-title":"Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties","volume":"27","author":"Yu","year":"2017","journal-title":"Glycobiology"},{"key":"10.1016\/j.autrev.2026.104148_bb0650","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jaci.2015.01.004","article-title":"Expression of ligands for Siglec-8 and Siglec-9 in human airways and airway cells","volume":"135","author":"Jia","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2026.104148_bb0655","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1024\/0301-1526\/a001031","article-title":"Vascular adhesion protein-1 (VAP-1) in vascular inflammatory diseases","volume":"51","author":"Danielli","year":"2022","journal-title":"VASA Z Gefasskrankheiten"},{"key":"10.1016\/j.autrev.2026.104148_bb0660","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1007\/s12350-023-03371-8","article-title":"Vascular adhesion protein-1-targeted PET imaging in autoimmune myocarditis","volume":"30","author":"Jahandideh","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.autrev.2026.104148_bb0670","doi-asserted-by":"crossref","first-page":"1448157","DOI":"10.3389\/fmed.2024.1448157","article-title":"Vascular-adhesion protein 1 in giant cell arteritis and polymyalgia rheumatica","volume":"11","author":"Petzinna","year":"2024","journal-title":"Front Med"},{"key":"10.1016\/j.autrev.2026.104148_bb0675","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s12026-023-09398-w","article-title":"Integrated analyses delineate distinctive immunological pathways and diagnostic signatures for Behcet\u2019s disease by leveraging gene microarray data","volume":"71","author":"Zhan","year":"2023","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2026.104148_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106695","article-title":"Soluble Siglec-9 alleviates intestinal inflammation through inhibition of the NF-\u03baB pathway","volume":"86","author":"Kang","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2026.104148_bb0685","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s11307-023-01885-8","article-title":"Detection of intestinal inflammation by vascular adhesion Protein-1-targeted [68Ga]Ga-DOTA-Siglec-9 positron emission tomography in murine models of inflammatory bowel disease","volume":"26","author":"Bhowmik","year":"2024","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.autrev.2026.104148_bb0570","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1021\/acscentsci.0c01669","article-title":"Synthetic Siglec-9 agonists inhibit neutrophil activation associated with COVID-19","volume":"7","author":"Delaveris","year":"2021","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.autrev.2026.104148_bb0710","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2012408118","article-title":"Modulation of immune cell reactivity with cis-binding Siglec agonists","volume":"118","author":"Delaveris","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2026.104148_bb0715","first-page":"1025","article-title":"Monocyte Siglec-14 expression is upregulated in patients with systemic lupus erythematosus and correlates with lupus disease activity","volume":"56","author":"Thornhill","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2026.104148_bb0690","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3389\/fimmu.2017.01601","article-title":"Sialic acids in the immune response during sepsis","volume":"8","author":"Liu","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104148_bb0695","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.897390","article-title":"Integrated analysis of gene co-expression network and prediction model indicates immune-related roles of the identified biomarkers in sepsis and sepsis-induced acute respiratory distress syndrome","volume":"13","author":"Ming","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104148_bb0700","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aab3459","article-title":"Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammation","volume":"7","author":"Spence","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2026.104148_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178297","article-title":"From plasma proteomics Mendelian randomization to neuropathological validation: the potential role of CTSH-GRN-TMEM106B and TREM2-IL-34 networks of microglia in Alzheimer\u2019s disease","volume":"1007","author":"Yuan","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.autrev.2026.104148_bb0765","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1093\/brain\/awaf018","article-title":"Mendelian randomization identifies proteins involved in neurodegenerative diseases","volume":"148","author":"Belbasis","year":"2025","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.autrev.2026.104148_bb0735","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216359","article-title":"The genetic regulation of protein expression in cerebrospinal fluid","volume":"15","author":"Hansson","year":"2023","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.autrev.2026.104148_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2024.112538","article-title":"Identification of potential drug targets for amyotrophic lateral sclerosis by Mendelian randomization analysis based on brain and plasma proteomics","volume":"195","author":"Yang","year":"2024","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.autrev.2026.104148_bb0730","doi-asserted-by":"crossref","first-page":"12032","DOI":"10.1038\/s41598-025-95229-x","article-title":"Novel serum biomarker associations with 7 tesla MRI-defined cortical lesions, leptomeningeal enhancement, and deep gray matter volume in early multiple sclerosis","volume":"15","author":"Miclea","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2026.104148_bb0775","article-title":"Conditioned medium from the stem cells of human exfoliated deciduous teeth ameliorates neuropathic pain in a partial sciatic nerve ligation model","volume":"13","author":"Liu","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.autrev.2026.104148_bb0780","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12953-024-00236-x","article-title":"Multi-targeted Olink proteomics analyses of cerebrospinal fluid from patients with aneurysmal subarachnoid hemorrhage","volume":"22","author":"Ding","year":"2024","journal-title":"Proteome Sci"},{"key":"10.1016\/j.autrev.2026.104148_bb0785","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3390\/jcm11040996","article-title":"Proteomics-based serum alterations of the human protein expression after out-of-hospital cardiac arrest: pilot study for prognostication of survivors vs. non-survivors at day 1 after return of spontaneous circulation (ROSC)","volume":"11","author":"Hinkelbein","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2026.104148_bb0755","doi-asserted-by":"crossref","DOI":"10.3390\/metabo15060366","article-title":"Soluble Siglec-9 improves intestinal barrier function in a mouse model of metabolic dysfunction-associated steatohepatitis","volume":"15","author":"Muto","year":"2025","journal-title":"Metabolites"},{"key":"10.1016\/j.autrev.2026.104148_bb0750","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1007\/s11357-023-00764-y","article-title":"Plasma levels of neurology-related proteins are associated with cognitive performance in an older population with overweight\/obesity and metabolic syndrome","volume":"45","author":"Llaurador-Coll","year":"2023","journal-title":"GeroScience"},{"key":"10.1016\/j.autrev.2026.104148_bb0790","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12929-020-00698-z","article-title":"Siglec-E retards atherosclerosis by inhibiting CD36-mediated foam cell formation","volume":"28","author":"Hsu","year":"2021","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.autrev.2026.104148_bb0795","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.974353","article-title":"Identification and exploration of novel M2 macrophage-related biomarkers in the development of acute myocardial infarction","volume":"9","author":"Zhou","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.autrev.2026.104148_bb0800","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/bloodadvances.2023011611","article-title":"Aberrant GPA expression and regulatory function of red blood cells in sickle cell disease","volume":"8","author":"Marshall","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.autrev.2026.104148_bb0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2019.102399","article-title":"Decreased erythrocyte binding of Siglec-9 increases neutrophil activation in sickle cell disease","volume":"81","author":"Kiser","year":"2020","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.autrev.2026.104148_bb0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115665","article-title":"The human sialic acid-binding immunoglobulin-like lectin Siglec-9 and its murine homolog Siglec-E control osteoclast activity and bone resorption","volume":"143","author":"Andes","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.autrev.2026.104148_bb0390","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s43018-023-00603-1","article-title":"SIGLEC9 tips the myeloid balance in glioblastoma","volume":"4","author":"Marron","year":"2023","journal-title":"Nat Cancer"},{"key":"10.1016\/j.autrev.2026.104148_bb0395","article-title":"High expression levels of SIGLEC9 indicate poor outcomes of glioma and correlate with immune cell infiltration","volume":"12","author":"Xu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.autrev.2026.104148_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17111799","article-title":"Identification of an immune-related gene signature for prognostic prediction in glioblastoma: insights from integrated bulk and single-cell RNA sequencing","volume":"17","author":"Chen","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.autrev.2026.104148_bb0405","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3390\/pharmaceutics16070953","article-title":"Glioma-associated sialoglycans drive the immune suppressive phenotype and function of myeloid cells","volume":"16","author":"Cornelissen","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.autrev.2026.104148_bb0415","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13048-023-01207-0","article-title":"MUC16 stimulates neutrophils to an inflammatory and immunosuppressive phenotype in ovarian cancer","volume":"16","author":"Wu","year":"2023","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.autrev.2026.104148_bb0420","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1021\/acssensors.0c00567","article-title":"Plasmonic nanoparticle-based digital cytometry to quantify MUC16 binding on the surface of leukocytes in ovarian cancer","volume":"5","author":"Jeong","year":"2020","journal-title":"ACS Sens"},{"key":"10.1016\/j.autrev.2026.104148_bb0425","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1600-0897.2012.01113.x","article-title":"The mucin MUC16 (CA125) binds to NK cells and monocytes from peripheral blood of women with healthy pregnancy and preeclampsia","volume":"68","author":"Tyler","year":"2012","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.autrev.2026.104148_bb0430","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-9-118","article-title":"Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes","volume":"9","author":"Belisle","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1016\/j.autrev.2026.104148_bb0435","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13048-025-01620-7","article-title":"Potential drug targets for ovarian cancer identified through Mendelian randomization and colocalization analysis","volume":"18","author":"Liu","year":"2025","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.autrev.2026.104148_bb0465","article-title":"Construction and validation of a immune-related prognostic gene DHRS1 in hepatocellular carcinoma based on bioinformatic analysis","volume":"102","author":"Xu","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2026.104148_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.mbplus.2022.100105","article-title":"Immunosuppressive glycoproteins associate with breast tumor fibrosis and aggression","volume":"14","author":"Metcalf","year":"2022","journal-title":"Matrix Biol Plus"},{"key":"10.1016\/j.autrev.2026.104148_bb0495","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1178817","article-title":"Disruption of the sialic acid\/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells","volume":"14","author":"Lustig","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104148_bb0500","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15133405","article-title":"Sialic acids on tumor cells modulate IgA therapy by neutrophils via inhibitory receptors Siglec-7 and Siglec-9","volume":"15","author":"Chan","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.autrev.2026.104148_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.107926","article-title":"Single-cell RNA-seq reveals the metabolic status of immune cells response to immunotherapy in triple-negative breast cancer","volume":"169","author":"Liu","year":"2024","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.autrev.2026.104148_bb0515","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12859-022-04841-5","article-title":"Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patients","volume":"23","author":"Shi","year":"2022","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.autrev.2026.104148_bb0530","doi-asserted-by":"crossref","first-page":"1036019","DOI":"10.3389\/fimmu.2023.1036019","article-title":"Multi-omics analysis of Siglec family genes in cutaneous melanoma","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104148_bb0565","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03393-22","article-title":"Siglec-9 restrains antibody-dependent natural killer cell cytotoxicity against SARS-CoV-2","volume":"14","author":"Saini","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.autrev.2026.104148_bb0595","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/glycob\/cwp111","article-title":"Genetic and biochemical modulation of sialic acid O-acetylation on group B Streptococcus: phenotypic and functional impact","volume":"19","author":"Weiman","year":"2009","journal-title":"Glycobiology"},{"key":"10.1016\/j.autrev.2026.104148_bb0610","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01107-24","article-title":"Neisserial adhesin a (NadA) binds human Siglec-5 and Siglec-14 with high affinity and promotes bacterial adhesion\/invasion","volume":"15","author":"Benucci","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.autrev.2026.104148_bb0625","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/CM9.0000000000001381","article-title":"Sialic acid-binding immunoglobulin-like lectin 9 as a potential therapeutic target for chronic obstructive pulmonary disease","volume":"134","author":"Chen","year":"2021","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.autrev.2026.104148_bb0630","first-page":"1119","article-title":"New insights into treatment of chronic obstructive pulmonary disease by targeting macrophages via sialic acid-binding immunoglobulin like lectin 9","volume":"44","author":"Ge","year":"2021","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"10.1016\/j.autrev.2026.104148_bb0665","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2967\/jnumed.120.250696","article-title":"First-in-humans study of 68Ga-DOTA-Siglec-9, a PET ligand targeting vascular adhesion protein 1","volume":"62","author":"Viitanen","year":"2021","journal-title":"J Nuclear Med"},{"key":"10.1016\/j.autrev.2026.104148_bb0705","first-page":"18","article-title":"Feasibility of (68)Ga-labeled Siglec-9 peptide for the imaging of acute lung inflammation: a pilot study in a porcine model of acute respiratory distress syndrome","volume":"6","author":"Retamal","year":"2016","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.1016\/j.autrev.2026.104148_bb0720","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.imlet.2010.10.009","article-title":"Expression profiles of novel cell surface molecules on B-cell subsets and plasma cells as analyzed by flow cytometry","volume":"134","author":"Llin\u00e0s","year":"2011","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2026.104148_bb0725","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.autrev.2008.03.015","article-title":"Natural anti-Siglec autoantibodies mediate potential immunoregulatory mechanisms: implications for the clinical use of intravenous immunoglobulins (IVIg)","volume":"7","author":"von Gunten","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104148_bb0740","doi-asserted-by":"crossref","first-page":"22127","DOI":"10.1074\/jbc.M002775200","article-title":"Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways","volume":"275","author":"Angata","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2026.104148_bb0745","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.lfs.2018.11.049","article-title":"Immunoregulatory Siglec ligands are abundant in human and mouse aorta and are up-regulated by high glucose","volume":"216","author":"Zhang","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.autrev.2026.104148_bb0820","article-title":"Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1\/PD-L1 therapy in non-small cell lung cancer patients","volume":"13","author":"Akbar","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104148_bb0825","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13550-014-0045-3","article-title":"(68)Ga-DOTA-Siglec-9 PET\/CT imaging of peri-implant tissue responses and staphylococcal infections","volume":"4","author":"Ahtinen","year":"2014","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.autrev.2026.104148_bb0840","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23020305","article-title":"Exploring alternative radiolabeling strategies for sialic acid-binding immunoglobulin-like lectin 9 peptide: [68Ga]Ga- and [18F]AlF-NOTA-Siglec-9","volume":"23","author":"Moisio","year":"2018","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.autrev.2026.104148_bb0845","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/jlcr.3525","article-title":"Exploring the radiosynthesis and in vitro characteristics of [68 Ga]Ga-DOTA-Siglec-9","volume":"60","author":"Jensen","year":"2017","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.autrev.2026.104148_bb0850","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1039\/C3CC40738A","article-title":"Translating the concept of peptide labeling with 5-deoxy-5-[18F]fluororibose into preclinical practice: 18F-labeling of Siglec-9 peptide for PET imaging of inflammation","volume":"49","author":"Li","year":"2013","journal-title":"Chem Commun (Camb)"},{"key":"10.1016\/j.autrev.2026.104148_bb0860","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.778989","article-title":"Development of Siglec-9 blocking antibody to enhance anti-tumor immunity","volume":"11","author":"Choi","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.autrev.2026.104148_bb0865","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107424118","article-title":"Siglecs-7\/9 function as inhibitory immune checkpoints in vivo and can be targeted to enhance therapeutic antitumor immunity","volume":"118","author":"Ibarlucea-Benitez","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2026.104148_bb0875","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1007\/s10875-010-9411-8","article-title":"Cell death modulation by intravenous immunoglobulin","volume":"30","author":"von Gunten","year":"2010","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2026.104148_bb0895","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/13543776.2025.2462849","article-title":"Small molecules targeting immune checkpoint proteins for cancer immunotherapy: a patent and literature review (2020-2024)","volume":"35","author":"Geng","year":"2025","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.autrev.2026.104148_bb0915","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3390\/ijms19010239","article-title":"Implication of soluble forms of cell adhesion molecules in infectious disease and tumor: insights from transgenic animal models","volume":"19","author":"Ono","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2026.104148_bb0920","doi-asserted-by":"crossref","DOI":"10.1038\/srep44043","article-title":"Secreted ectodomain of SIGLEC-9 and MCP-1 synergistically improve acute liver failure in rats by altering macrophage polarity","volume":"7","author":"Ito","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2026.104148_bb0925","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1523\/JNEUROSCI.4088-14.2015","article-title":"Secreted ectodomain of sialic acid-binding Ig-like lectin-9 and monocyte chemoattractant protein-1 promote recovery after rat spinal cord injury by altering macrophage polarity","volume":"35","author":"Matsubara","year":"2015","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2026.104148_bb0935","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2312374120","article-title":"Dual-inhibitory domain iCARs improve the efficiency of the AND-NOT gate CAR T strategy","volume":"120","author":"Bangayan","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2026.104148_bb0940","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/mc.23213","article-title":"Targeting glycosylated antigens on cancer cells using siglec-7\/9-based CAR T-cells","volume":"59","author":"Meril","year":"2020","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.autrev.2026.104148_bb0945","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/2326-6066.CIR-24-0429","article-title":"Transforming the dark into light: a Siglec-9 switch","volume":"12","author":"Abken","year":"2024","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.autrev.2026.104148_bb0950","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1158\/2326-6066.CIR-23-0823","article-title":"Targeting tumor-associated sialic acids using chimeric switch receptors based on Siglec-9 enhances the antitumor efficacy of engineered T cells","volume":"12","author":"Eisenberg","year":"2024","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.autrev.2026.104148_bb0815","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092072","article-title":"Characterization of cell-bound CA125 on immune cell subtypes of ovarian cancer patients using a novel imaging platform","volume":"13","author":"Gonz\u00e1lez","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.autrev.2026.104148_bb0830","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7645070","article-title":"Comparison of 68Ga-DOTA-Siglec-9 and 18F-Fluorodeoxyribose-Siglec-9: inflammation imaging and radiation dosimetry","volume":"2017","author":"Virtanen","year":"2017","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.autrev.2026.104148_bb0855","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s41181-025-00396-x","article-title":"Establishment and validation of an alternative automated synthesis of [68Ga]Ga-DOTA-Siglec-9 in an independent laboratory for clinical use","volume":"10","author":"Migliari","year":"2025","journal-title":"EJNMMI Radiopharm Chem"},{"key":"10.1016\/j.autrev.2026.104148_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.136635","article-title":"A bispecific antibody targeting the Ig domains of Siglec-E displays enhanced antitumor effects","volume":"281","author":"Zhao","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.autrev.2026.104148_bb0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.02.007","article-title":"Granulocyte death mediated by specific antibodies in intravenous immunoglobulin (IVIG)","volume":"154","author":"Graeter","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.autrev.2026.104148_bb0885","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1398-9995.2011.02579.x","article-title":"Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes","volume":"66","author":"Schaub","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.autrev.2026.104148_bb0890","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1182\/blood-2006-05-021568","article-title":"Immunologic and functional evidence for anti-Siglec-9 autoantibodies in intravenous immunoglobulin preparations","volume":"108","author":"von Gunten","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2026.104148_bb0900","doi-asserted-by":"crossref","first-page":"11014","DOI":"10.1002\/anie.201205831","article-title":"Click and pick: identification of sialoside analogues for siglec-based cell targeting","volume":"51","author":"Rillahan","year":"2012","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.autrev.2026.104148_bb0905","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114146","article-title":"Sugar nucleotide regeneration system for the synthesis of Bi- and triantennary N-glycans and exploring their activities against siglecs","volume":"232","author":"Anwar","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.autrev.2026.104148_bb0910","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s12967-022-03714-y","article-title":"Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal\/GalNAc epitopes elicit anti-tumor immunity","volume":"20","author":"Huang","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.autrev.2026.104148_bb0930","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.micpath.2016.08.014","article-title":"A soluble form of Siglec-9 provides a resistance against group B Streptococcus (GBS) infection in transgenic mice","volume":"99","author":"Saito","year":"2016","journal-title":"Microb Pathog"},{"key":"10.1016\/j.autrev.2026.104148_bb0955","doi-asserted-by":"crossref","first-page":"14211","DOI":"10.1073\/pnas.1409580111","article-title":"Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer","volume":"111","author":"L\u00e4ubli","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2026.104148_bb0960","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/s41598-017-01404-0","article-title":"IVIG regulates the survival of human but not mouse neutrophils","volume":"7","author":"Schneider","year":"2017","journal-title":"Sci Rep"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722600162X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722600162X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:04:18Z","timestamp":1792857858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899722600162X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":191,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S156899722600162X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104148","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Siglec-9: A pivotal immune checkpoint connecting immune homeostasis with the pathogenesis of multiple diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104148"}}